Macrophages are recruited to tumor sites primarily through the CCL2/CCR2 axis and CSF-1/CSF-1R signaling, so blocking these two signaling axes also reduces macrophage infiltration (219–221). The gene discussed is CCR2; the disease is neoplasm.